Statistics
Publications
3
Citations
64
H-Index
3
Active since
2004
Affiliations
K. Kim is an author at The University of Texas MD Anderson Cancer Center specializing in malignant neoplasms, metastatic melanoma treatment, and melanoma pharmacotherapy.
Publications per year
2004–2006
3
3
Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)
Omar Eton, L. Billings, K. Kim et al. · Journal of Clinical Oncology · 2004 · 42 citations
Medicine, Cancer Biology, Oncology +16
Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)
Omar Eton, L. Billings, K. Kim et al. · Journal of Clinical Oncology · 2004 · 12 citations
Medicine, Cancer Biology, Oncology +16
1–3 of 3